DR Horton is a residential construction business based in the US. DR Horton shares (DHI) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $126.81 – an increase of 0.66% over the previous week. DR Horton employs 14,766 staff and has a trailing 12-month revenue of around $36.7 billion.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $126.81 |
|---|---|
| 52-week range | $124.23 - $198.79 |
| 50-day moving average | $138.73 |
| 200-day moving average | $160.46 |
| Wall St. target price | $167.27 |
| PE ratio | 8.9483 |
| Dividend yield | $1.3 (1.24%) |
| Earnings per share (TTM) | $14.13 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $126.44 from 2025-02-27
| 1 week (2025-02-21) | 0.37% |
|---|---|
| 1 month (2025-01-31) | -10.89% |
| 3 months (2024-11-29) | -25.09% |
| 6 months (2024-08-30) | -33.02% |
| 1 year (2024-03-01) | -17.34% |
|---|---|
| 2 years (2023-03-01) | 41.61% |
| 3 years (2022-03-01) | 51.72% |
| 5 years (2020-02-28) | 149.51% |
Valuing DR Horton stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of DR Horton's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
DR Horton's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, DR Horton shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
DR Horton's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.5042. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into DR Horton's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
DR Horton's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.1 billion.
The EBITDA is a measure of a DR Horton's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $36.7 billion |
|---|---|
| Operating margin TTM | 14.04% |
| Gross profit TTM | $9 billion |
| Return on assets TTM | 10.93% |
| Return on equity TTM | 19.17% |
| Profit margin | 12.69% |
| Book value | $78.53 |
| Market Capitalization | $40.6 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like DR Horton.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 28
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and DR Horton's overall score of 28 (as at 12/31/2018) is pretty good – landing it in it in the 32nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like DR Horton is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 13.47/100
DR Horton's environmental score of 13.47 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that DR Horton is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 15.42/100
DR Horton's social score of 15.42 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that DR Horton is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 14.6/100
DR Horton's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that DR Horton is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. DR Horton scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that DR Horton has, for the most part, managed to keep its nose clean.
DR Horton Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 28 |
|---|---|
| Total ESG percentile | 32.48 |
| Environmental score | 13.47 |
| Environmental score percentile | 9 |
| Social score | 15.42 |
| Social score percentile | 9 |
| Governance score | 14.6 |
| Governance score percentile | 9 |
| Level of controversy | 2 |
Dividend payout ratio: 9.89% of net profits
Recently DR Horton has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), DR Horton shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In DR Horton's case, that would currently equate to about $1.3 per share.
While DR Horton's payout ratio might seem low, this can signify that DR Horton is investing more in its future growth.
DR Horton's most recent dividend payout was on 13 February 2025. The latest dividend was paid out to all shareholders who bought their shares by 6 February 2025 (the "ex-dividend date").
DR Horton's shares were split on a 4:3 basis on 16 March 2005 . So if you had owned 3 shares the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your DR Horton shares – just the quantity. However, indirectly, the new 25% lower share price could have impacted the market appetite for DR Horton shares which in turn could have impacted DR Horton's share price.
Over the last 12 months, DR Horton's shares have ranged in value from as little as $124.23 up to $198.7907. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while DR Horton's is 1.762. This would suggest that DR Horton's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
D. R. Horton, Inc. operates as a homebuilding company in East, North, Southeast, South Central, Southwest, and Northwest regions in the United States. It engages in the acquisition and development of land; and construction and sale of residential homes in 125 markets across 36 states under the names of D. R. Horton.
Microsoft, IBM, IONQ, Rigetti and Quantum Computing are some of the top stocks to buy in this category. See how to get started here.
These are the stocks to buy when you don’t have much to spend.
Learn how to invest in AI and capitalize on this rapidly growing industry.
Here are the best dividend stocks so far of the year based on dividend yield and analyst ratings.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
Yes, you can trade penny stocks on Robinhood. Here are some of the top penny stocks to buy on Robinhood and how to get started.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
A deep dive into the highlights and limitations of Robinhood.